Appili Therapeutics Inc.

Appili Therapeutics Inc.verified

APLIF

Price:

$0.015

Market Cap:

$3.03M

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for F...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

APLIF

The Enterprise Value as of December 2025 (TTM) for Appili Therapeutics Inc. (APLIF) is 14.26M

According to Appili Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.26M. This represents a change of -0.10% compared to the average of 14.27M of the last 4 quarters.

Appili Therapeutics Inc. (APLIF) Historical Enterprise Value (quarterly & annually)

How has APLIF Enterprise Value performed in the past?

The mean historical Enterprise Value of Appili Therapeutics Inc. over the last ten years is 19.85M. The current 14.26M Enterprise Value has changed 7.08% with respect to the historical average. Over the past ten years (40 quarters), APLIF's Enterprise Value was at its highest in in the September 2020 quarter at 71.33M. The Enterprise Value was at its lowest in in the December 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

19.85M

Median

15.31M

Minimum

6.32M

Maximum

55.66M

Appili Therapeutics Inc. (APLIF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Appili Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 302.24%

Maximum Annual Enterprise Value = 55.66M

Minimum Annual Increase = -88.64%

Minimum Annual Enterprise Value = 6.32M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202515.31M24.13%
202412.33M26.53%
20239.75M54.21%
20226.32M-88.64%
202155.66M302.24%
202013.84M-30.55%
201919.92M-10.34%
201822.22M-4.69%

Appili Therapeutics Inc. (APLIF) Average Enterprise Value

How has APLIF Enterprise Value performed in the past?

The current Enterprise Value of Appili Therapeutics Inc. (APLIF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.46M

5-year avg

19.87M

10-year avg

19.85M

Appili Therapeutics Inc. (APLIF) Enterprise Value vs. Peers

How is APLIF’s Enterprise Value compared to its peers?

Appili Therapeutics Inc.’s Enterprise Value is greater than Algernon Pharmaceuticals Inc. (2.65M), greater than ReNeuron Group plc (-5684904.70), greater than Ayala Pharmaceuticals, Inc. (7.85M), greater than Universal Ibogaine Inc. (3.95M), greater than Restart Life Sciences Corp. (3.44M), greater than Regen BioPharma, Inc. (1.32M), greater than VG Life Sciences Inc. (2.11M), greater than America Great Health (4.75M), greater than Imagion Biosystems Limited (6.83M), greater than Health Sciences Group, Inc. (505.72K),

Build a custom stock screener for Appili Therapeutics Inc. (APLIF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Appili Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Appili Therapeutics Inc. (APLIF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Appili Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Appili Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Appili Therapeutics Inc. (APLIF)?

What is the 3-year average Enterprise Value for Appili Therapeutics Inc. (APLIF)?

What is the 5-year average Enterprise Value for Appili Therapeutics Inc. (APLIF)?

How does the current Enterprise Value for Appili Therapeutics Inc. (APLIF) compare to its historical average?